Literature DB >> 18082619

Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability.

Kwan-Bok Lee1, Jun-Ho Jeon, Inpyo Choi, O-Yu Kwon, Kweon Yu, Kwan-Hee You.   

Abstract

Clusterin (CLU) is known as a multifunctional protein involved in a variety of physiological processes including lipid transport, epithelial cell differentiation, tumorigenesis, and apoptosis. It is known that CLU interacts with TGF-beta type ll receptor (TbetaRll). However, the relationship of CLU and TGF-beta signaling is unclear. Here we present that CLU is a novel modulator of TGF-beta signaling by regulating Smad2/3 proteins. Overexpression of CLU enhanced TGF-beta-induced transcriptional activity and increased the amount of Smad2/3 proteins, while CLU siRNA repressed TGF-beta-induced transcriptional activity and decreased the amount of Smad2/3 proteins in Hep3B cells. We also found that CLU was involved in Smad2/3 stability at the protein level. These findings suggest that CLU regulates TGF-beta signaling pathway by modulating the stability of Smad2/3 proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082619     DOI: 10.1016/j.bbrc.2007.12.033

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Authors:  Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

2.  Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer.

Authors:  Amina Zoubeidi; Kim Chi; Martin Gleave
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

3.  Clusterin attenuates the development of renal fibrosis.

Authors:  Gwon-Soo Jung; Mi-Kyung Kim; Yun-A Jung; Hye-Soon Kim; In-Sun Park; Bon-Hong Min; Ki-Up Lee; Jung-Guk Kim; Keun-Gyu Park; In-Kyu Lee
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

4.  Clusterin signals via ApoER2/VLDLR and induces meiosis of male germ cells.

Authors:  Muhammad Assad Riaz; Angelika Stammler; Mareike Borgers; Lutz Konrad
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

5.  Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer.

Authors:  Roya Navab; Dan Strumpf; Bizhan Bandarchi; Chang-Qi Zhu; Melania Pintilie; Varune Rohan Ramnarine; Emin Ibrahimov; Nikolina Radulovich; Lisa Leung; Malgorzata Barczyk; Devang Panchal; Christine To; James J Yun; Sandy Der; Frances A Shepherd; Igor Jurisica; Ming-Sound Tsao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-07       Impact factor: 11.205

Review 6.  Targeting heat shock proteins in metastatic castration-resistant prostate cancer.

Authors:  Arun A Azad; Amina Zoubeidi; Martin E Gleave; Kim N Chi
Journal:  Nat Rev Urol       Date:  2014-12-16       Impact factor: 14.432

Review 7.  Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Mst Marium Begum; Md Siddiqul Islam; Tapan Behl; Ghulam Md Ashraf
Journal:  Neurotox Res       Date:  2020-08-21       Impact factor: 3.911

Review 8.  The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.

Authors:  S Park; K W Mathis; I K Lee
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

9.  A signaling network in phenylephrine-induced benign prostatic hyperplasia.

Authors:  Jayoung Kim; Yutaka Yanagihara; Tadahiko Kikugawa; Mihee Ji; Nozomu Tanji; Yokoyama Masayoshi; Michael R Freeman
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

10.  Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation.

Authors:  Yong Tang; Fenghua Liu; Chunning Zheng; Shaochuan Sun; Yingsheng Jiang
Journal:  J Exp Clin Cancer Res       Date:  2012-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.